PAUL R MENARD
Nursing in North Wales, PA
License number
Pennsylvania RN543502
Category
Nursing
Type
Registered Nurse
Address
Address
North Wales, PA 19454
Personal information
See more information about PAUL R MENARD at radaris.comName
Address
Phone
240 Hawthorne Cir, North Wales, PA 19454
3214 Ash Mill Rd, Doylestown, PA 18901
240 Hawthorne Cir, North Wales, PA 19454
Professional information
Treatment Of Conditions Requiring Enhanced Oxygen Availability To Mammalian Tissues
US Patent:
4861795, Aug 29, 1989
Filed:
Jun 23, 1988
Appl. No.:
7/211486
Inventors:
John T. Suh - Maple Glen PA
Robert G. Pendelton - Hatfield PA
Charles E. Pendley - Abington PA
Kin T. Yu - Collegeville PA
Paul R. Menard - North Wales PA
Alain B. Schreiber - Fort Washington PA
Robert G. Pendelton - Hatfield PA
Charles E. Pendley - Abington PA
Kin T. Yu - Collegeville PA
Paul R. Menard - North Wales PA
Alain B. Schreiber - Fort Washington PA
Assignee:
Rorer Pharmaceutical Corporation - Fort Washington PA
International Classification:
A61K 3121, A61K 3119, A61K 31195
US Classification:
514510
Abstract:
Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
Treatment Of Conditions Requiring Enhanced Oxygen Availability To Mammalian Tissues
US Patent:
4849416, Jul 18, 1989
Filed:
Jul 25, 1988
Appl. No.:
7/223585
Inventors:
Robert G. Pendleton - Hatfield PA
Charles E. Pendley - Abington PA
John T. Suh - Maple Glen PA
Kin T. Yu - Collegeville PA
Paul R. Menard - North Wales PA
Tihamer Herczeg - Perkiomenville PA
Charles E. Pendley - Abington PA
John T. Suh - Maple Glen PA
Kin T. Yu - Collegeville PA
Paul R. Menard - North Wales PA
Tihamer Herczeg - Perkiomenville PA
Assignee:
Rorer Pharmaceutical Corporation - Fort Washington PA
International Classification:
A61K 31655
US Classification:
514150
Abstract:
Disclosed are pharmaceutical compositions containing certain heterocylcic sulphonamido azo compounds for enhancing oxygen availability to mammalian tissue.
Treatment Of Conditions Requiring Enhanced Oxygen Availability Of Mammalian Tissues
US Patent:
5015663, May 14, 1991
Filed:
Mar 5, 1990
Appl. No.:
7/488190
Inventors:
John T. Suh - Maple Glen PA
Robert G. Pendleton - Hatfield PA
Charles E. Pendley - Abington PA
Kin T. Yu - Collegeville PA
Paul R. Menard - North Wales PA
Alain B. Schreiber - Fort Washington PA
Robert G. Pendleton - Hatfield PA
Charles E. Pendley - Abington PA
Kin T. Yu - Collegeville PA
Paul R. Menard - North Wales PA
Alain B. Schreiber - Fort Washington PA
Assignee:
Rhone-Poulenc Rorer Pharmaceuticals Inc. - Fort Washington PA
International Classification:
A61K 3121, A61K 3119, A61K 3140, A61K 3155
US Classification:
514510
Abstract:
Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.
Treatment Of Conditions Requiring Enhanced Oxygen Availability To Mammalian Tissues
US Patent:
4948582, Aug 14, 1990
Filed:
May 11, 1989
Appl. No.:
7/333520
Inventors:
John T. Suh - Maple Glen PA
Robert G. Pendleton - Hatfield PA
Charles E. Pendley - Abington PA
Kin T. Yu - Collegeville PA
Paul R. Menard - North Wales PA
Alain B. Schreiber - Fort Washington PA
Robert G. Pendleton - Hatfield PA
Charles E. Pendley - Abington PA
Kin T. Yu - Collegeville PA
Paul R. Menard - North Wales PA
Alain B. Schreiber - Fort Washington PA
Assignee:
Rorer Pharmaceutical Corporation - Ft. Washington PA
International Classification:
A61K 3121, A61K 3119, A61K 31195
US Classification:
424529
Abstract:
Disclosed are pharmaceutical compositions containing naphthoic acid derivatives and method of use for enhancing oxygen availability to mammailian tissue.